It will support the structuring and connection to ECRIN of disease-, technology-, or product-oriented investigation networks and hubs focusing on specific areas: rare diseases (WP4), medical device (WP5), nutrition (WP6).
Transnational access activities will support the cost of multinational extension of clinical trials on rare diseases, medical device and nutrition selected by the ECRIN scientific board (WP7).
Joint research activities are designed to improve the efficiency of ECRIN services, through the development of tools for risk-adapted monitoring (WP8), and the upgrade of the VISTA data management tool (WP9).
As part of the end of the pool of Conventions ECRIN
3 operators (expected late 2013), the La Poste Group seeks to reconstruct a new pool can cover the needs of the DISIT in terms of telecommunications services for the duration of this contract.